BrightSpring Health Services (BTSG) investor relations material

Business overview and strategy

• Provides integrated home and community services for specialty and senior populations, segmented into pharmacy and provider services.

• Focuses on operational synergies, lean efficiency, and market-leading teams to drive above-market growth.

• Pursues highly accretive M&A, completing about 80 deals in 10 years with nearly all improving post-acquisition results.

• Leverages scale for better payer and procurement negotiations, and cross-business best practice deployment.

• Invests in technology and differentiated payment models to enhance patient outcomes and operational efficiency.

Growth drivers and financial outlook

• Specialty pharmacy growth is driven by investments made years prior, with strong visibility into future opportunities.

• Provider segment posted over 30% growth, with mid-teens historical growth and ongoing geographic expansion.

• Infusion and home and community pharmacy targeted for significant expansion, with operational improvements via AI.

• Maintains strong balance sheet to support capital deployment and consolidation in attractive markets.

• Continues to invest in AI and technology while leveraging corporate infrastructure for future growth.

Pharmacy segment details

• Operates in specialty pharmacy (oncology, rare diseases, LDDs), home infusion (non-oncology), and home/community pharmacy (serving senior facilities, IDD, hospice).

• Differentiates through high-quality service, rapid medication delivery, and high adherence and satisfaction scores.

• LDD launches (16-20 annually) provide multi-year growth visibility; biosimilars are a future opportunity, not a current risk.

• Specialty pharmacy expected to outpace other segments, with infusion targeted for outsized growth.

• PBM reform monitored closely, but no significant impact anticipated on operations.